亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

肉豆蔻酰六肽-23(抗菌肽)六勝肽

 
 
單價 1.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 1000g起訂1g
品牌 成都云希
CAS號 N/A
純度 ≥98%
分子量 909.3g/mol
過期 長期有效
更新 2021-07-02 10:35
 

成都云希化工有限公司

企業會員第6年
資料未認證
保證金未繳納
詳細說明

云希產品簡介----肉豆蔻酰六肽-23

痤瘡丙酸桿菌,能分泌可降解皮膚角質及類脂成分的酯酶等代謝物,是痤瘡的最主要病因之一.

 

云希產品參數----肉豆蔻酰六肽-23

 

中文名稱:肉豆蔻酰六肽-23(抗菌肽)

英文名稱:Myristoyl Hexapeptide-23, sympeptide380

CAS號:N/A

純度:≥98%

分子量 :909.3g/mol

分子式 :C47H92N10O7

外觀:白色粉末或液體

儲存條件:2 ℃~8 ℃

包裝規格(粉末):1g, 10g, 100g

包裝規格(液體):20ml/瓶,1KG/瓶

應用:化妝品原料

 

云希功效與應用----肉豆蔻酰六肽-23

滅痤瘡丙酸桿菌,控油祛痘、抗痤瘡抗粉刺

 

云希作用機理----肉豆蔻酰六肽-23

YSPep-HXP23為肉豆蔻酰六肽-23(Myritoyl Hexapeptide-23),可以殺滅痤瘡丙酸桿菌,幫助預防皮膚問題,特別適合各種控油祛痘、粉刺產品。

舉報收藏 0評論 0
更多>本企業其它產品
云希專注勝肽乙酰基六肽-49/DELISENS 乙酰基六肽-1 乙酰基四肽-2 三肽-10瓜氨酸/核心蛋白聚糖肽 Polypeptide-23 乙酰基六肽-7抗衰多肽 Sh-Decapeptide-7 Oligopeptide-21/寡肽21
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |